Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey.

Ferré VM, Ekouevi DK, Gbeasor-Komlanvi FA, Collin G, Le Hingrat Q, Tchounga B, Salou M, Descamps D, Charpentier C, Dagnra AC.

Clin Microbiol Infect. 2019 Apr 30. pii: S1198-743X(19)30191-0. doi: 10.1016/j.cmi.2019.04.015. [Epub ahead of print]

PMID:
31051265
2.

Prevalence and distribution of Human Papillomavirus (HPV) genotypes among HIV infected women in Lomé, Togo.

Nyasenu YT, Gbeasor-Komlanvi FA, Ehlan A, Issa SA, Dossim S, Kolou M, Yambiyo BM, Prince-David M, Salou M, Ekouevi DK, Dagnra A.

PLoS One. 2019 Feb 27;14(2):e0212516. doi: 10.1371/journal.pone.0212516. eCollection 2019.

3.

Resistance profile of children and adolescents infected with HIV-1 in urban areas in Togo.

Takassi OE, Salou M, Djadou KE, Agbéko F, Agbèrè D, Géraldo R, Dagnra A, Atakouma Y.

Med Sante Trop. 2018 Nov 1;28(4):419-423. doi: 10.1684/mst.2018.0860.

4.

Prevalence of Human Papillomavirus, HIV and other sexually transmitted infections among men having sex with men in Togo: a national cross-sectional survey.

Ferré VM, Gbeasor-Komlanvi FA, Collin G, Dagnra AC, Le Hingrat Q, Jaquet A, Salou M, Descamps D, Charpentier C, Ekouevi DK.

Clin Infect Dis. 2018 Dec 6. doi: 10.1093/cid/ciy1012. [Epub ahead of print]

PMID:
30520971
5.

Occurrence of carbapenemase-producing Enterobacteriaceae in Togo, West Africa.

Dossim S, Bonnin RA, Salou M, Tanga K, Godonou V, Dagnra AY, Prince David M, Naas T, Dortet L.

Int J Antimicrob Agents. 2019 Apr;53(4):530-532. doi: 10.1016/j.ijantimicag.2018.11.019. Epub 2018 Nov 24. No abstract available.

PMID:
30476571
6.

Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries.

Ngo-Giang-Huong N, Huynh THK, Dagnra AY, Toni TD, Maiga AI, Kania D, Eymard-Duvernay S, Peeters M, Soulie C, Peytavin G, Rekacewicz C, Chaix ML, Aghokeng AF; ANRS 12333 Study Group .

J Antimicrob Chemother. 2019 Feb 1;74(2):462-467. doi: 10.1093/jac/dky443.

7.

Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo.

Tsolenyanu E, Djadou KE, Fiawoo M, Akolly DAE, Mwenda JM, Leshem E, Tate JE, Aliabadi N, Koudema W, Guedenon KM, Godonou M, Dagnra A, Gbadoe AD, Boko A, Landoh D, Atakouma Y, Parashar UD.

Vaccine. 2018 Nov 12;36(47):7185-7191. doi: 10.1016/j.vaccine.2018.01.058. Epub 2018 Feb 1.

PMID:
29397224
8.

Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.

Ngabonziza JCS, Diallo AB, Tagliani E, Diarra B, Kadanga AE, Togo ACG, Thiam A, de Rijk WB, Alagna R, Houeto S, Ba F, Dagnra AY, Ivan E, Affolabi D, Schwoebel V, Trebucq A, de Jong BC, Rigouts L, Daneau G; “Union short MDR-TB regimen study group”.

PLoS One. 2017 Oct 31;12(10):e0187211. doi: 10.1371/journal.pone.0187211. eCollection 2017.

9.

The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance.

Gehre F, Otu J, Kendall L, Forson A, Kwara A, Kudzawu S, Kehinde AO, Adebiyi O, Salako K, Baldeh I, Jallow A, Jallow M, Dagnra A, Dissé K, Kadanga EA, Idigbe EO, Onubogu C, Onyejepu N, Gaye-Diallo A, Ba-Diallo A, Rabna P, Mane M, Sanogo M, Diarra B, Dezemon Z, Sanou A, Senghore M, Kwambana-Adams BA, Demba E, Faal-Jawara T, Kumar S, Tientcheu LD, Jallow A, Ceesay S, Adetifa I, Jaye A, Pallen MJ, D'Alessandro U, Kampmann B, Adegbola RA, Mboup S, Corrah T, de Jong BC, Antonio M.

BMC Med. 2016 Nov 3;14(1):160.

10.

Hepatitis B infection in HIV-1-infected patients receiving highly active antiretroviral therapy in Lomé, Togo: Prevalence and molecular consequences.

Patassi A, Benaboud S, Landoh DE, Salou M, Dagnra AC, Saka B, Krivine A, Meritet JF, Pitché P, Salmon-Ceron D.

S Afr Med J. 2016 May 10;106(6). doi: 10.7196/SAMJ.2016.v106i6.10312.

PMID:
27245734
11.

Genetic diversity and transmission networks of HIV-1 strains among men having sex with men (MSM) in Lomé, Togo.

Konou AA, Vidal N, Salou M, Anato S, Singo-Tokofaï A, Ekouevi DK, Pitché P, Prince-David M, Delaporte E, Peeters M, Dagnra AY.

Infect Genet Evol. 2016 Dec;46:279-285. doi: 10.1016/j.meegid.2016.05.030. Epub 2016 May 25.

PMID:
27235597
12.

High Rates of Drug Resistance Among Newly Diagnosed HIV-infected Children in the National Prevention of Mother-to-child Transmission Program in Togo.

Salou M, Butel C, Konou AA, Ekouevi DK, Vidal N, Dossim S, Lawson-Evi K, Nyasenu YT, Singo-Tokofaï A, d'Almeida S, Tchama R, Delaporte E, Prince-David M, Peeters M, Dagnra AY.

Pediatr Infect Dis J. 2016 Aug;35(8):879-85. doi: 10.1097/INF.0000000000001203.

PMID:
27167115
13.

High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo.

Salou M, Dagnra AY, Butel C, Vidal N, Serrano L, Takassi E, Konou AA, Houndenou S, Dapam N, Singo-Tokofaï A, Pitche P, Atakouma Y, Prince-David M, Delaporte E, Peeters M.

J Int AIDS Soc. 2016 Apr 27;19(1):20683. doi: 10.7448/IAS.19.1.20683. eCollection 2016.

14.

Early Evidence of Impact of Monovalent Rotavirus Vaccine in Togo.

Tsolenyanu E, Mwenda JM, Dagnra A, Leshem E, Godonou M, Nassoury I, Landoh D, Tate JE, Atakouma Y, Parashar UD.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S196-9. doi: 10.1093/cid/civ1182.

PMID:
27059356
15.

Virological outcome among HIV-1 infected patients on first-line antiretroviral treatment in semi-rural HIV clinics in Togo.

Konou AA, Salou M, Vidal N, Kodah P, Kombate D, Kpanla P, Nabroulaba T, Nyametso D, Singo-Tokofaï A, Pitche P, Delaporte E, Prince-David M, Peeters M, Dagnra AY.

AIDS Res Ther. 2015 Nov 27;12:38. doi: 10.1186/s12981-015-0082-7. eCollection 2015.

16.

Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo.

Konou AA, Dagnra AY, Vidal N, Salou M, Adam Z, Singo-Tokofai A, Delaporte E, Prince-David M, Peeters M.

AIDS. 2015 Nov 28;29(18):2527-30. doi: 10.1097/QAD.0000000000000906.

PMID:
26558549
17.

Prevalence of multidrug-resistant tuberculosis cases among HIV-positive and HIV-negative patients eligible for retreatment regimen in Togo using GeneXpert MTB/RIF.

Dagnra AY, Mlaga KD, Adjoh K, Kadanga E, Disse K, Adekambi T.

New Microbes New Infect. 2015 Sep 10;8:24-27. doi: 10.1016/j.nmni.2015.09.001. eCollection 2015 Nov.

18.

Evaluation of 9 rapid diagnostic tests for screening HIV infection, in Lomé, Togo.

Dagnra AY, Dossim S, Salou M, Nyasenu T, Ali-Edje K, Ouro-Médeli A, Doufan M, Ehlan A, Prince-David M.

Med Mal Infect. 2014 Dec;44(11-12):525-9. doi: 10.1016/j.medmal.2014.10.007. Epub 2014 Nov 7.

PMID:
25391806
19.

Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.

Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Touré-Kane C, Truong LX, Chaix ML, Delaporte E, Ayouba A, Peeters M; ANRS 12235 Study Group.

J Clin Microbiol. 2014 Feb;52(2):578-86. doi: 10.1128/JCM.02860-13. Epub 2013 Dec 11.

20.

[HIV seroprevalence among drug users in Togo].

Ekouevi DK, Coffie PA, Salou M, Kariyiare BG, Dagnra AC, Tchounga B, Prince-Davi M, Becquet R, Pitche VP.

Sante Publique. 2013 Jul-Aug;25(4):491-8. French.

PMID:
24404731
21.

Surveillance for rotavirus gastroenteritis in children less than 5 years of age in Togo.

Tsolenyanu E, Seheri M, Dagnra A, Djadou E, Tigossou S, Nyaga M, Adjeoda E, Armah G, Mwenda JM, Atakouma Y.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S14-8. doi: 10.1097/INF.0000000000000046.

PMID:
24343607
22.

National surveillance data on the epidemiology of cholera in Togo.

Landoh DE, Gessner BD, Badziklou K, Tamekloe T, Nassoury DI, Dagnra A, Patassi A, Tante O, Bidjada B, Tigossou S, Banla KA.

J Infect Dis. 2013 Nov 1;208 Suppl 1:S115-9. doi: 10.1093/infdis/jit244. Erratum in: J Infect Dis. 2014 May 1;209(9):1494. Essoya, Landoh Dadja [corrected to Landoh, Dadja Essoya]; Kossi, Badziklou [corrected to Badziklou, Kossi]; Tsidi, Tamekloe [corrected to Tamekloe, Tsidi]; Ibrahim, Nassoury Dalandi [corrected to Nassoury, Danlai Ibrahim]; Anoumou, Dagnra [corrected to Dag.

PMID:
24101639
23.

Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.

Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni TD, Touré-Kane C, Truong LX, Delaporte E, Chaix ML, Peeters M, Ayouba A; ANRS 12186 Study Group.

Clin Infect Dis. 2014 Jan;58(1):99-109. doi: 10.1093/cid/cit627. Epub 2013 Sep 27.

PMID:
24076968
24.

HIV seroprevalence among inmates in Togo.

Ekouevi DK, D'almeida S, Salou M, Kariyiare BG, Coffie PA, Dagnra AC, Tchounga B, Becquet R, Prince-David M, Pitche VP.

Med Mal Infect. 2013 Jul;43(7):279-85. doi: 10.1016/j.medmal.2013.06.002. Epub 2013 Jul 29.

PMID:
23906419
25.

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.

Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW.

J Infect Dis. 2013 Jun 15;207 Suppl 2:S70-7. doi: 10.1093/infdis/jit114.

26.

[Becoming new pulmonary tuberculosis patients with sputum smear-positive at the end of second month of anti tubercular treatment in Lome].

Adjoh KS, Watéba MI, Fiogbé AA, Adambounou AS, Gbadamassi AG, Efalou PJ, Boukari M, Awanou GB, Wachinou AP, Kounta C, Dagnra A, Tidjani O.

Mali Med. 2013;28(4):32-36. French.

PMID:
30049152
27.

High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo.

Dagnra AY, Vidal N, Mensah A, Patassi A, Aho K, Salou M, Monleau M, Prince-David M, Singo A, Pitche P, Delaporte E, Peeters M.

J Int AIDS Soc. 2011 Jun 10;14:30. doi: 10.1186/1758-2652-14-30.

28.

[Prevalence of methicillin-resistant Staphylococcus aureus in community-acquired skin infections in Lomé, Togo].

Kombaté K, Dagnra AY, Saka B, Mouhari-Toure A, Akakpo S, Tchangaï-Walla K, Pitché P.

Med Trop (Mars). 2011 Feb;71(1):68-70. French.

PMID:
21585096
29.

[Prevalence of HIV-TB co-infection and impact of HIV infection on pulmonary tuberculosis outcome in Togo].

Dagnra AY, Adjoh K, Tchaptchet Heunda S, Patassi AA, Sadzo Hetsu D, Awokou F, Tidjani O.

Bull Soc Pathol Exot. 2011 Dec;104(5):342-6. doi: 10.1007/s13149-010-0079-3. Epub 2010 Sep 4. French.

PMID:
20821178
30.

[Pediatric salmonellosis at the Tokoin's teaching hospital, Lomé (Togo)].

Gbadoé AD, Lawson-Evi K, Dagnra AY, Guédénon K, Géraldo A, Djadou E, Kodom M, Prince-David M.

Med Mal Infect. 2008 Jan;38(1):8-11. Epub 2007 Dec 21. French.

PMID:
18160240
31.

[Emergence of multidrug resistant Salmonella strains in Lome (Togo)].

Dagnra AY, Akolly K, Gbadoe A, Aho K, David M.

Med Mal Infect. 2007 May;37(5):266-9. Epub 2007 Apr 24. French.

PMID:
17459634
32.

[Human immunodeficiency virus, hepatitis C virus and hepatitis B viruses in patients with sickle-cell disease in Togo].

Ségbéna AY, Prince-David M, Kagoné TS, Dagnra AY.

Transfus Clin Biol. 2005 Dec;12(6):423-6. Epub 2006 Jan 18. French.

PMID:
16414299
33.

[Incidence and impact of HIV infection among patients with bacterial pleurisy in Lomé (Togo)].

Dagnra AY, Gbadoé AH, Edorh TK, Prince-David M, Tidjani O, Sadzo DH.

Med Mal Infect. 2004 May;34(5):216-20. French.

PMID:
16235598
34.

[Genital bacterial carriage during the last trimester of pregnancy and early-onset neonatal sepsis].

Balaka B, Agbèrè A, Dagnra A, Baeta S, Kessie K, Assimadi K.

Arch Pediatr. 2005 May;12(5):514-9. French.

PMID:
15885539
35.

[New Staphylococcus aureus strains].

Dagnra AY, Tristan A, Gillet Y, Etienne J.

Rev Prat. 2004 May 31;54(10):1053-8. Review. French.

PMID:
15369145
36.

[Evaluation of eight diagnostic tests for HIV infection in Lome (Togo)].

Dagnra AY, Prince David M, Gaba J, Ouro-Akpo MT, Segbena AY, Ali-Edje K, Ehlan A, Bougoudogo F.

Med Trop (Mars). 2002;62(5):507-10. French.

PMID:
12616943
37.

[Acute osteomyelitis in the child with sickle cell disease in a tropical zone: value of oral fluoroquinolones].

Gbadoé AD, Dogba A, Dagnra AY, Atakouma Y, Tékou H, Assimadi JK.

Arch Pediatr. 2001 Dec;8(12):1305-10. French.

PMID:
11811024
38.

[Antimicrobial activity of ciprofloxacin and netilmicin compared to various antibiotics in Lome, Togo].

Dagnra AY, Prince-David M, Hounkpati A.

Sante. 2001 Jan-Feb;11(1):63-6. French.

39.

[Frequency and susceptibility to antibiotics of Neisseria gonorrhoeae at Lomé].

Dagnra AY, David M.

Sante. 1999 Sep-Oct;9(5):332-4. French.

Supplemental Content

Loading ...
Support Center